Evaluates treatment outcomes in older adults with peripheral T cell lymphoma, suggesting new therapeutic approaches.
The peripheral T cell lymphomas (PTCL) represent about 10% of all non-Hodgkin lymphomas (NHLs) and have an aggressive course compared to their B-cell counterparts [1]. In the updated WHO classifica...
No takes yet. Share an insight, caveat, or question.
Faisal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: